Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Е. В. Парамонова
Observed names:
E Paramonova,
E V Paramonova,
E. Paramonova,
E. V. Paramonova,
E.V. Paramonova,
Evgenia Paramonova,
Парамонова Е.В.
show all 7
Institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
Observed institutions:
Russian Cancer Research Center NN Blokhin,
National Medical Research Center for Hematology,
Ministry of Health of the Russian Federation
ORCID:
0009-0008-7886-7671
Observed ORCID:
0009-0008-7886-7671
OpenAlex ID:
A5114072934
[Treating patients with acute myeloid leukemias (AML) according to the protocol of the AML-01.10 Russian multicenter randomized trial: the coordinating center's results].
2014
·
E N Parovichnikova
, V V Troitskaia
, et al.
·
PubMed
·
14
First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)
2017
·
Elena Andreevna Demina
, A. A. Leont’eva
, et al.
·
Clinical oncohematology
·
13
PDF
Relevance of Positron-Emission Therapy for Optimization of Treatment of Advanced Hodgkin’s Lymphoma Using Intensive ЕАСОРР-14 Program
2017
·
Elena Andreevna Demina
, A. A. Leont’eva
, et al.
·
Clinical oncohematology
·
4
PDF
Treatment of Patients with Relapsed/Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Own Data and Literature Review
2025
·
Arman Vachakanovich Arakelyan
, G. S. Tumyan
, et al.
·
Clinical oncohematology
·
1
PDF
Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Experience in Treating 131 Patients at a National Medical Research Center in Russia
2019
·
I. Z. Zavodnova
, M. Yu. Kichigina
, et al.
·
Clinical oncohematology
·
1
PDF
Experience with prolgolimab in the treatment of patients with relapsed and refractory classical Hodgkin lymphoma
2025
·
Valeria Shpirko
, Anastasia Semenova
, et al.
·
Blood
Options for Program Chemotherapy and Their Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Based on the Data from a Single Center
2025
·
Ulyana Gordeevna Koshkina
, G. S. Tumyan
, et al.
·
Clinical oncohematology
PDF
Diffuse Large B-Cell Lymphoma with High Risk of Central Nervous System Damage: A Literature Review, Prevention, Treatment, and Prognosis
2025
·
Selmi Faikovna Ramazanova
, A. V. Arakelyan
, et al.
·
Clinical oncohematology
PDF
Pb2309: Outcomes of 22 Patients With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma: Single Institute Experience
2023
·
Gayane Tumyan
, Arman Arakelyan
, et al.
·
HemaSphere
Pb2259: the New Pd-1 Inhibitor Prolgolimab in the Treatment of Patients With Relapsed/refractory Classical Hodgkin’s Lymphoma
2023
·
Anastasia Semenova
, Shpirko Valeria
, et al.
·
HemaSphere
UPDATED SAFETY AND EFFICACY RESULTS OF «HLMoscow 1‐3» STUDY FOR THE 147 UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA
2019
·
G. Tumyan
, M. Kichigina
, et al.
·
Hematological Oncology
Место лучевой терапии в современном лечении лимфомы Ходжкина
2015
·
Demina Ea
, А. А. Леонтьева
, et al.
·
Злокачественные опухоли
Conventional 7+3 Consolidation Is Equal in Long-Term Outcome to High Dose ARA-C in Case of the High Total Doses of Different Anthracyclines/Anthracenedione in Induction/Consolidation - the Interim Results of Russian Randomized Multicenter AML-10 Trial
2014
·
Valeri G Savchenko
, Elena N. Parovichnikova
, et al.
·
Blood
Особенности индукционной терапии больных с гиперлейкоцитозом в дебюте острого миелобластного лейкоза
2014
·
В В Троицкая
, Е. Н. Паровичникова
, et al.
·
Гематология и трансфузиология
Show more works
View as search
Works count:
15
Citation count:
33
H-index:
3
I10-index:
2
Year
Topic
Type